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Lentiviral Hematopoietic Stem Cell Gene Therapy for MNGIE
----------------------------------------------------------------------------
1- Due to the relatively high risks associated with allogeneic hematopoietic stem cell transplantation  
 for the treatment of MNGIE and its limited therapeutic outcomes, promising alternative   
 treatments such as gene therapy should be pursued. 
 This thesis
2- To achieve long-lasting gene correction in MNGIE patients, ex vivo culture and lentiviral vector  
 transduction conditions should not impede the repopulation and self-renewal capacities of
	 	gene-modified	hematopoietic	stem	and	progenitor	cells.
 This thesis
3- Lentiviral vectors have a preference to integrate in highly expressed genes, and do not  selectively  
 integrate near proto-oncogenes, a pattern that is conserved between species, and is not affected by  
 the promoters or transgenes used in this thesis.
 This thesis
4- In addition to neuro- or myo-genic changes, alterations to the interstitial cells of Cajal (the gut’s 
 pacemakers) are observed in the intestines of MNGIE patients.
 This thesis
5-	 The	preclinical	results	reported	here	and	elsewhere	support	the	efficacy	of	LV-mediated	
 hematopoietic stem cell gene therapy as a treatment for MNGIE without evident signs of   
 genotoxicity. However, assessment of the treatment’s impact on additional clinical phenotypes and  
 the in-depth evaluation of its safety, are required prior to the initiation of clinical trials.
 This thesis
6- Gene therapy returns to centre stage.
 Naldini, L. Nature 2015; 526 (7573):351-60
7-	 Autologous	LV-mediated	HSCGT	does	not	necessarily	require	myeloablative	conditioning,	and		
 bears a low genotoxicity risk while offering long-lasting therapeutic outcomes. 
 Aiuti, A. et al., Science 2013; 341 (6148): 1233151-1-12
8- Targeted genome editing holds great promise to cure hereditary and acquired diseases. Optimizati 
	 on	of	in	vivo	targeting,	and	adequate	evaluation	of	the	specificity	and	off-targeting	of	the		 	
 engineered nucleases are major challenges.
 Cornu, T.I. et al., Nature Medicine 2017; 23 (4): 415-423
9- The clinical translational value of animal models could be improved by: appropriate design and  
 execution of experiments, inclusion of safety and quality of life parameters, validation and   
 humanization of the model, introducing clinical trial endpoints, and back translation from   
 clinical trials to animal models.
 Denayer, T. et al., New Horizons in Translational Medicine 2014; 2 (1): 5-11
10- The four fundamental needs to keep employees productive and devoted to their job are trust,  
 opportunity to advance, sense of worth, and competence.
 Branham, L. 2005; ISBN: 0-8144-0851-6
11- Be strong enough to stand alone, smart enough to know when you need help, and brave enough to  
 ask for it.
 (Author unknown)
           
                       Rana Yadak, 2017
